---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-015153"
form_type: "8-K"
ticker: "OMDA"
cik: "0001611115"
company_name: "Omada Health, Inc."
filed_at: "2026-03-05T23:59:59+00:00"
generated_at: "2026-05-15T19:40:24.420911+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Omada Health Q4 revenue $76M (+58% YoY), achieves positive net income of $5M

## Summary
- Q4 revenue $76M (+58% YoY); full-year $260M (+53% YoY). GAAP net income $5M in Q4 vs ($8M) loss prior year.
- Full-year net loss narrowed to $13M from $47M; adjusted EBITDA turned positive at $6M vs ($29M) in 2024.
- Total members reached 886,000 (+55% YoY); GLP-1 supported members tripled to over 150,000.
- Gross margin improved: Q4 GAAP 71% (up from 67%), full-year 66% (up from 61%).
- Launched new products: GLP-1 Flex Care, OmadaSpark, Meal Map, and Omada for Cholesterol (Feb 2026).

## SEC filing metadata
- accession: 0001628280-26-015153
- form_type: 8-K
- ticker: OMDA
- cik: 0001611115
- company_name: Omada Health, Inc.
- filed_at: 2026-03-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1611115/000162828026015153/0001628280-26-015153-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1611115/000162828026015153/omda-20260305.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-015153
- JSON: https://secwatch.observer/filing/0001628280-26-015153.json
- Plain text: https://secwatch.observer/filing/0001628280-26-015153.txt

## Key facts
- Earnings Releases
  Omada Health, Inc. reported the fourth quarter ended December 31, 2025 results: revenue $76 million, net income $5 million.
  - Period: the fourth quarter ended December 31, 2025
  - Revenue: $76 million
  - Net income: $5 million
  - Result: reported results
  source text: Revenue • $76 million in the fourth quarter, up 58% year over year • $260 million for the full year, up 53% compared with 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1611115/000162828026015153/0001628280-26-015153-index.htm
- Earnings Releases
  Omada Health, Inc. reported the full year ended December 31, 2025 results: revenue $260 million, net income net loss of $13 million.
  - Period: the full year ended December 31, 2025
  - Revenue: $260 million
  - Net income: net loss of $13 million
  - Result: reported results
  source text: and full year 2025, except where otherwise noted. Total members • 886,000 at year end, up 55% year over year Revenue • $76 million in the fourth quarter, up 58% year over year • $260 million for the full year, up 53% compared with 2024 GLP-1 Leadership • Omada has now supported more than 150,000 members on GLP-1s, compared with more than 50,000 at the end of 2024 •
  evidence_url: https://www.sec.gov/Archives/edgar/data/1611115/000162828026015153/0001628280-26-015153-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.